Table 1 Bivariate associations of history of HCV infection, PTSD, mental health problems, and population characteristics
Variables | Total (N = 263) | History of HCV infection (N = 168) | PTSD (N = 111) | Any mental health problems (N = 158) | ||||
|---|---|---|---|---|---|---|---|---|
n (median) | % (IQR) | n (median) | % (IQR) | n (median) | % (IQR) | n (median) | % (IQR) | |
Age in years | 26.1 | (22.6–28.2) | 26.9 | (24.0–28.4) † | 26.7 | (22.6–28.2) | 26.2 | (22.5–28.2) |
Age category | ||||||||
< 25 years | 107 | 41.0% | 53 | 50.0% † | 44 | 41.1% | 67 | 62.6% |
25 years | 154 | 59.0% | 115 | 75.7% | 67 | 43.5% | 91 | 59.1% |
Duration of IDU (years) | 4.2 | (2.0–8.6) | 5.4 | (3.3–9.6) † | 4.9 | (2.6–8.8) | 4.6 | (2.1–8.6) |
Age first injected | 19.0 | (17.0–23.0) | 19.0 | (17.0–22.0) † | 19.0 | (17.0–23.0) | 19.0 | (17.0–23.0) |
Sex at birth | ||||||||
Male | 148 | 56.7% | 101 | 69.2% | 50 | 33.8% † | 77 | 52.0% † |
Female | 113 | 43.3% | 67 | 59.8% | 61 | 54.0% | 81 | 71.7% |
Hispanic/Latino (a) | ||||||||
Yes | 227 | 87.6% | 146 | 64.9% | 92 | 40.5% | 133 | 58.6% † |
No | 32 | 12.4% | 21 | 67.7% | 18 | 56.3% | 24 | 75.0% |
Race | ||||||||
White | 151 | 58.8% | 94 | 63.5% | 66 | 43.7% | 96 | 63.6% |
Black | 7 | 2.7% | 2 | 28.6% | 4 | 57.1% | 5 | 71.4% |
Othera | 99 | 38.5% | 68 | 68.7% | 41 | 41.4% | 55 | 55.6% |
Education | ||||||||
Less than high school | 95 | 37.1% | 62 | 66.0% | 37 | 39.0% | 52 | 54.7% |
High school/GED and above | 161 | 62.9% | 104 | 64.6% | 74 | 46.0% | 106 | 65.8% |
Marital Status | ||||||||
Single/Never married | 211 | 82.4% | 131 | 62.4% † | 87 | 41.2% | 126 | 59.7% |
Not single | 45 | 17.6% | 35 | 77.8% | 24 | 53.3% | 32 | 71.1% |
Insurance/Medicaid | ||||||||
On Medicaid | 200 | 81.0% | 135 | 67.8% | 86 | 43.0% | 126 | 63.0% |
On non-Medicaid insurance | 27 | 10.9% | 16 | 59.3% | 16 | 59.3% | 19 | 70.4% |
No insurance | 20 | 8.1% | 11 | 55.0% | 5 | 25.0% | 9 | 45.0% |
Commercial sex work in last three months | ||||||||
Yes | 3 | 1.1% | 3 | 100% | 2 | 66.7% | 2 | 66.7% |
No | 260 | 98.9% | 165 | 64.7% | 109 | 41.9% | 156 | 60.0% |
Positive HCV antibody | ||||||||
Reactive | 156 | 60.9% | 156 | 100% | 73 | 46.8% | 101 | 64.7% |
Non-reactive | 100 | 39.1% | 10 | 10% | 37 | 37.0% | 55 | 55.0% |
Positive HCV RNA | ||||||||
Reactive | 105 | 45.7% | 105 | 100% | 45 | 42.9% | 67 | 63.8% |
Non-reactive | 125 | 54.3% | 39 | 31.2% | 51 | 40.8% | 74 | 59.2% |
Receptive syringe sharing | ||||||||
Yes | 135 | 53.4% | 104 | 77.0% † | 56 | 41.5% | 87 | 64.4% |
No | 118 | 46.6% | 61 | 51.7% | 54 | 45.8% | 69 | 58.5% |